BioCentury
ARTICLE | Translation in Brief

Translational tidbits

May 22, 2014 7:00 AM UTC

Berg Pharma LLC is seeking to validate its Interrogative Biology toolkit by striking academic partnerships with the University of Miami Miller School of Medicine and Medical University of South Carolina. Berg will use tissue banks and patient data from the medical schools to discover biomarkers and targets for cancer and cardiovascular, CNS, metabolic and autoimmune diseases.

The platform combines a patient's molecular data with clinical records and demographic data. The goal of the systems biology approach is to help doctors select treatment regimens and help insurance companies develop formularies...